David K. Li

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

Christian Confavreux, David K. Li, Mark S. Freedman et al. · Multiple Sclerosis Journal · 2012 · 140 citations · Full text

Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study

Anthony Traboulsee, Katherine Knox, Lindsay Machan et al. · The Lancet · 2013 · 94 citations

Venous Disease, Neurological Disorder, Catheter Venography +6

In vitro cytotoxic potential of friedelin in human MCF-7 breast cancer cell: Regulate early expression of Cdkn2a and pRb1, neutralize mdm2-p53 amalgamation and functional stabilization of p53

Pandurangan Subash‐Babu, David K. Li, Ali A. Alshatwi · Experimental and Toxicologic Pathology · 2017 · 38 citations

Vitro Cytotoxic Potential, Functional Stabilization, Breast Oncology +9

Safety and efficacy of venoplasty in MS

Anthony Traboulsee, Lindsay Machan, J Girard et al. · Neurology · 2018 · 28 citations · Full text

Regional Cerebral Glucose Metabolism in Never-Medicated Patients with Schizophrenia

Campbell Clark, Lili C. Kopala, David K. Li et al. · The Canadian Journal of Psychiatry · 2001 · 27 citations